Frontlight ResearchEarly access
Myelodysplastic syndromes trials in United States
224 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleLuspatercept + Darbepoetin in MDS
- Where
- Chicago, Columbus, Dallas, New Haven
- Age
- 18 years and over
- People
- 60
- Run by
- Yale University
See details and how to joinNCT07096297 - Phase 2Not yet taking people in United StatesDepletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
- Where
- Seattle
- People
- 52
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT07819396 - No phaseTaking peopleA Telehealth Advance Care Planning Intervention
- Where
- Rochester
- Age
- 60 years and over
- People
- 207
- Run by
- University of Rochester
See details and how to joinNCT05875805 - Phase 2Taking peopleA Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
- Where
- Houston, Miami
- Age
- 18 years and over
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06566742 - Phase 2Taking peopleAzacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- Where
- Baltimore, Cleveland, Houston
- Age
- 12 years and over
- People
- 63
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03383575 - Phase 1/2Taking peopleASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 42
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05010122 - Phase 3Taking peopleIvosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
- Where
- Boston, Chapel Hill, Chicago, Columbus, Dallas, Denver, Eugene, Houston, New York
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00 - Phase 2Taking peopleDose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
- Where
- Birmingham, Boston, Columbus
- Age
- 18 years and over
- People
- 124
- Run by
- Hannah Choe, MD
See details and how to joinNCT07249346 - Phase 2Taking peopleCPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 30
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04493164 - Phase 1/2Taking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Akron, Albany, Albuquerque, Allentown, Anchorage, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boise, Boston, Brooklyn, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Durham, East Lansing, El Paso, Falls Church, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Greenville, Hackensack, Hartford, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Maywood, Memphis, Mesa, Miami, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Neptune City, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Norfolk, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reno, Richmond, Roanoke, Rochester, Royal Oak, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Tucson, Valhalla, Washington D.C., West Palm Beach, Wilmington, Winfield, Winston-Salem
- Age
- Up to 22 years
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - Phase 1Taking peopleA Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Where
- Ann Arbor, Atlanta, Aurora, Birmingham, Boston, Chicago, Cincinnati, Houston, Indianapolis, Memphis, Minneapolis, New York, Orange, Philadelphia, Pittsburgh, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 1 year to 18 years
- People
- 36
- Run by
- Children's Oncology Group
See details and how to joinNCT06247787 - Phase 1Taking peopleStudy of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
- Where
- Palo Alto
- Age
- 18 months to 39 years
- People
- 12
- Run by
- Laguna Biotherapeutics, Inc.
See details and how to joinNCT07573111 - Phase 1Not yet taking people in United StatesStudy of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 42
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07780565 - No phaseTaking peopleImproving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
- Where
- Omaha
- Age
- 19 years and over
- People
- 114
- Run by
- University of Nebraska
See details and how to joinNCT04898790 - Phase 1Taking peopleEltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Where
- Memphis, Nashville
- Age
- 18 years and over
- People
- 60
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06399640 - Phase 1Taking peopleICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Where
- Chapel Hill, Milwaukee, New Haven, New York, Orange, Tampa
- Age
- 18 years and over
- People
- 266 worldwide
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06656494 - Phase 1Taking peopleThiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 48
- Run by
- Sawa Ito, MD
See details and how to joinNCT07565220 - Phase 1Taking peopleTACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
- Where
- Palo Alto
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Stanford University
See details and how to joinNCT07302776 - No phaseEnrolling by invitationPathogenesis of Hematologic Malignancies
- Where
- Portland
- Age
- 1 year and over
- People
- 5,000
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT01728402 - No phaseTaking peopleeHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
- Where
- Miami
- Age
- 18 years and over
- People
- 165
- Run by
- University of Miami
See details and how to joinNCT07469592 - Phase 2/3Taking peopleVenetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- Where
- Houston
- Age
- 18 years to 70 years
- People
- 324
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04708054 - Phase 2Taking peopleInterferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Pittsburgh, Seattle, St Louis
- Age
- 18 years and over
- People
- 57
- Run by
- Sawa Ito, MD
See details and how to joinNCT06529731 - Phase 1/2Taking peoplePhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Where
- Houston
- Age
- 12 years to 80 years
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092451 - Phase 2Enrolling by invitationA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Baltimore, Buffalo, Canton, Charleston, Chicago, Dallas, Fountain Valley, Grand Rapids, Hackensack, Houston, Kennewick, Nashville, Plantation, Portland, Rochester, San Antonio, Seattle
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - No phaseNot yet taking people in United StatesPRAISE-IR Versus CIBMTR Controls
- Where
- New York
- Age
- 1 year to 66 years
- People
- 51
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT07717164